AI Maverick Intel Issues Initial Shares for HEAL Access Canada Acquisition, Adjusts Consideration to 100 Million Shares

AI Maverick Intel Inc. (OTC: AIMV) has taken a significant step toward finalizing its proposed acquisition of HEAL Access Canada Inc. by issuing 76.5 million common shares to HEAL Group Holdings as the initial tranche of consideration under a Right of First Refusal Agreement dated Feb. 11, 2026. The company also announced an adjustment to the total consideration from 120 million to 100 million AIMV common shares, signaling ongoing negotiations as both parties work toward a definitive agreement. Additionally, AI Maverick Intel outlined plans to pursue an uplisting to the OTCQB Venture Market as part of its broader capital markets strategy, which could enhance its visibility and liquidity for investors.

The issuance of initial shares marks a critical milestone in the acquisition process, reflecting AI Maverick Intel's commitment to expanding its footprint in the healthcare and technology sectors. HEAL Access Canada Inc. is expected to bring synergies with AI Maverick's focus on artificial intelligence and data platforms, potentially enabling the combined entity to deliver innovative solutions in emerging technology-enabled industries. The adjustment in total consideration from 120 million to 100 million shares suggests a refined valuation based on due diligence and strategic alignment.

AI Maverick Intel's strategy includes identifying and developing opportunities at the intersection of AI, data platforms, and technology-driven sectors. The company evaluates strategic acquisitions, partnerships, and scalable platforms designed to drive long-term shareholder value. The proposed acquisition of HEAL Access Canada aligns with this vision, potentially integrating healthcare access solutions with AI and data analytics capabilities.

The planned uplisting to the OTCQB Venture Market represents a key step in enhancing the company's profile among investors. Trading on the OTCQB, which is a premier tier of the OTC Markets, could improve AIMV's access to capital and attract a broader investor base. This move underscores management's confidence in the company's growth trajectory and its commitment to corporate governance standards.

Investors can find the latest news and updates relating to AIMV in the company’s newsroom at http://ibn.fm/AIMV. The full press release detailing the share issuance and acquisition terms is available at https://ibn.fm/mivWz. As AI Maverick Intel advances its acquisition strategy and capital markets initiatives, stakeholders will be watching for the completion of the definitive agreement and the subsequent uplisting to the OTCQB.